BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26361272)

  • 1. Lymphopoiesis in transgenic mice over-expressing Artemis.
    Rivera-Munoz P; Abramowski V; Jacquot S; André P; Charrier S; Lipson-Ruffert K; Fischer A; Galy A; Cavazzana M; de Villartay JP
    Gene Ther; 2016 Feb; 23(2):176-86. PubMed ID: 26361272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
    Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
    Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced immunoglobulin class switch recombination in the absence of Artemis.
    Rivera-Munoz P; Soulas-Sprauel P; Le Guyader G; Abramowski V; Bruneau S; Fischer A; Pâques F; de Villartay JP
    Blood; 2009 Oct; 114(17):3601-9. PubMed ID: 19692705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for Artemis nuclease in the repair of radiation-induced DNA double strand breaks by alternative end joining.
    Moscariello M; Wieloch R; Kurosawa A; Li F; Adachi N; Mladenov E; Iliakis G
    DNA Repair (Amst); 2015 Jul; 31():29-40. PubMed ID: 25973742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
    Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
    Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the study of immunodeficiency and DNA damage response.
    Morio T
    Int J Hematol; 2017 Sep; 106(3):357-365. PubMed ID: 28550350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA Ligase IV Syndrome R278H Mutation Impairs B Lymphopoiesis via Error-Prone Nonhomologous End-Joining.
    Park J; Welner RS; Chan MY; Troppito L; Staber PB; Tenen DG; Yan CT
    J Immunol; 2016 Jan; 196(1):244-55. PubMed ID: 26608917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
    Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
    Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
    Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS
    DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and mechanistic insights into the Artemis endonuclease and strategies for its inhibition.
    Yosaatmadja Y; Baddock HT; Newman JA; Bielinski M; Gavard AE; Mukhopadhyay SMM; Dannerfjord AA; Schofield CJ; McHugh PJ; Gileadi O
    Nucleic Acids Res; 2021 Sep; 49(16):9310-9326. PubMed ID: 34387696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.
    Barthels C; Puchałka J; Racek T; Klein C; Brocker T
    PLoS One; 2013; 8(9):e74838. PubMed ID: 24069355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells.
    Rooney S; Alt FW; Lombard D; Whitlow S; Eckersdorff M; Fleming J; Fugmann S; Ferguson DO; Schatz DG; Sekiguchi J
    J Exp Med; 2003 Mar; 197(5):553-65. PubMed ID: 12615897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Specific nuclease activities of Artemis and the Artemis: DNA-PKcs complex.
    Chang HH; Lieber MR
    Nucleic Acids Res; 2016 Jun; 44(11):4991-7. PubMed ID: 27198222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
    Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
    Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
    Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
    J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.
    Moshous D; Callebaut I; de Chasseval R; Corneo B; Cavazzana-Calvo M; Le Deist F; Tezcan I; Sanal O; Bertrand Y; Philippe N; Fischer A; de Villartay JP
    Cell; 2001 Apr; 105(2):177-86. PubMed ID: 11336668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic interaction between the non-homologous end-joining factors during B and T lymphocyte development: In vivo mouse models.
    Castañeda-Zegarra S; Fernandez-Berrocal M; Tkachov M; Yao R; Upfold NLE; Oksenych V
    Scand J Immunol; 2020 Oct; 92(4):e12936. PubMed ID: 32654175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoinhibition of the Nuclease ARTEMIS Is Mediated by a Physical Interaction between Its Catalytic and C-terminal Domains.
    Niewolik D; Peter I; Butscher C; Schwarz K
    J Biol Chem; 2017 Feb; 292(8):3351-3365. PubMed ID: 28082683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.